2K3 Stock Overview
A medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
SI-BONE, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$14.70 |
| 52 Week High | US$19.90 |
| 52 Week Low | US$11.00 |
| Beta | 1.23 |
| 11 Month Change | 27.83% |
| 3 Month Change | 10.53% |
| 1 Year Change | -9.26% |
| 33 Year Change | -20.11% |
| 5 Year Change | -9.82% |
| Change since IPO | -12.19% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2K3 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0% | -1.0% | -0.02% |
| 1Y | -9.3% | -7.3% | 8.2% |
Return vs Industry: 2K3 underperformed the German Medical Equipment industry which returned -7.3% over the past year.
Return vs Market: 2K3 underperformed the German Market which returned 8.2% over the past year.
Price Volatility
| 2K3 volatility | |
|---|---|
| 2K3 Average Weekly Movement | 8.6% |
| Medical Equipment Industry Average Movement | 5.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: 2K3's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 2K3's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 344 | Laura Francis | si-bone.com |
SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion.
SI-BONE, Inc. Fundamentals Summary
| 2K3 fundamental statistics | |
|---|---|
| Market cap | €505.83m |
| Earnings (TTM) | -€35.92m |
| Revenue (TTM) | €150.80m |
3.4x
P/S Ratio-14.1x
P/E RatioIs 2K3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2K3 income statement (TTM) | |
|---|---|
| Revenue | US$157.04m |
| Cost of Revenue | US$35.02m |
| Gross Profit | US$122.02m |
| Other Expenses | US$159.42m |
| Earnings | -US$37.40m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.89 |
| Gross Margin | 77.70% |
| Net Profit Margin | -23.82% |
| Debt/Equity Ratio | 21.9% |
How did 2K3 perform over the long term?
See historical performance and comparison